Award

Delivery Order #SPE2DR26F7DZ7

Delivery Order for Ondansetron Tablets Under AmerisourceBergen IDV Contract

Buyer

Defense Logistics Agency

Award Amount

$3,695.27

Ceiling

$3,695.27

Awarded

March 09, 2026

Period of Performance

Mar 09, 2026 – Mar 10, 2026

Identifier

SPE2DR26F7DZ7

NAICS

424210

This award is a delivery order contract assigned to AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor, under an existing indefinite delivery vehicle (IDV) contract focused on pharmaceutical services. The contract involves procuring Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting, reflecting the agency's continued commitment to securing essential pharmaceutical supplies. The contract's scope includes timely delivery of these tablets, supporting healthcare operations efficiently within a brief, defined timeframe. This delivery order was competitively issued under the established IDV, emphasizing streamlined procurement processes for critical medical products. The performance period is short-term, covering a two-day window, ensuring prompt fulfillment of the agency's needs. This award complements previous significant contracts with AmerisourceBergen that span long-term pharmaceutical provision, demonstrating ongoing collaboration in healthcare support services.

Description

4571088197!ONDANSETRON HCL 4 MG TABLET 30S

View original record